HLA-B*15:02 is associated with anemia in patients with chronic hepatitis C treated with pegylated interferon-α and ribavirin

Tseng C.-W.Hsieh Y.-H.CHIN-KUO CHANGLai N.-S.Hung T.-H.Wu S.-F.Tseng K.-C.2020-08-212020-08-2120120001-2815https://www.scopus.com/inward/record.uri?eid=2-s2.0-84866896927&doi=10.1111%2fj.1399-0039.2012.01956.x&partnerID=40&md5=637c1130493381b6466fbdf2a4356777https://scholars.lib.ntu.edu.tw/handle/123456789/513308[SDGs]SDG3HLA-B*15:02 is associated with anemia in patients with chronic hepatitis C treated with pegylated interferon-α and ribavirinjournal article10.1111/j.1399-0039.2012.01956.x229314072-s2.0-84866896927